Robust response to virus variants expected in former COVID patients and the vaccinated
By
Alicia Lasek
Mar 31, 2021
Blood samples from recovered COVID-19 patients show that they and their vaccinated peers should be able to fend off the virus and its variants in future encounters, NIH researchers say.
Clinical briefs for Monday, Sept. 20
By
Alicia Lasek
Sep 20, 2021
CNAs remain least vaccinated, requiring ‘large-scale’ solution … AARP says Florida leads nation in COVID deaths of nursing home residents, staff … Hardware-free virtual physical therapy system...
Clinical briefs for Thursday, Sept. 16
By
Alicia Lasek
Sep 16, 2021
U.S. to limit states’ access to COVID antibody treatments as demand rises … Aggressively reducing Alzheimer’s risk factors could mean 1.2 million fewer cases in 2050: experts … NIH launches nationwide...
U.S. to test vaccine combos for future anti-variant strategy, Fauci says
By
Alicia Lasek
Apr 01, 2022
The NIH is launching a phase 2 clinical trial to help determine which vaccine combos can provide a broader immune response in adults who have already had a series of COVID-19 vaccinations.
Clinical briefs for Monday, Aug. 23
By
Alicia Lasek
Aug 23, 2021
FDA pushing to fully approve Pfizer COVID vaccine this week … Accessible strength training nearly equals effect of drugs in lowering blood pressure, experts find … Need for yearly COVID shot may not...
Clinical briefs for Monday, June 28
By
Alicia Lasek
Jun 28, 2021
To save itself, Medicare could deny coverage of controversial new Alzheimer’s drug, expert predicts … Aduhelm most appropriate for early dementia, MCI, experts say … Eli Lilly to seek early approval...
SNF-linked wound clinics saw fewer patients during pandemic but unchanged outcomes
By
Alicia Lasek
Nov 10, 2021
Investigators expected that wound outcomes would be adversely affected by pandemic disruptions. But data from hundreds of wound care clinics in the United States show otherwise.
CDC: Turn to Paxlovid to treat COVID-19, not steroids or antibiotics
By
Alicia Lasek (f3)
Apr 26, 2022
The agency is urging clinicians to consider the now readily available, recommended therapies such as Paxlovid as first-line COVID-19 treatments.
Insomnia increases odds of memory decline in older adults
By
Alicia Lasek
Sep 07, 2022
Insomnia may be an important target for early intervention to help prevent age-related cognitive decline, investigators say.
Nursing home study reveals ‘dramatic’ fluctuations in prescribing of COVID-19 meds
By
Alicia Lasek
May 26, 2023
Investigators tracked the use of COVID-19 medications in 11 U.S. nursing home chains, describing prescribing patterns that shed new light on the challenges of pandemic clinical care.